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Abstract: Several lines of evidence point to leucomyosuppressin (LMS) and myosuppressin-related 
peptides as inhibitory modulators of heartbeat frequency in arthropods. Previous studies in Blattella 
germanica demonstrated that heartbeat frequency decreases after ootheca formation, and remains low 
during the period of ootheca transport.  Subsequent work in this cockroach resulted in the 
characterization of LMS and the cloning and sequencing of its precursor. The present paper describes 
the activity of LMS on modulation of heartbeat in B. germanica. Assays using semi-isolated heart 
preparations revealed that LMS reduces heartbeat frequency in a dose dependent manner, at 
physiological concentrations. Additional experiments showed that LMS inhibits heart beat rates in 
vivo. Finally, injection of dsRNA for LMS elicited a decrease in LMS mRNA to virtually undetectable 
levels and heartbeat frequency increased significantly in females carrying oothecae. These data suggest 
that LMS contributes to the modulation of cardiac rhythm in B. germanica during the reproductive 
cycle. 
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Previous studies demonstrated that cardiac rhythm decreases after ootheca formation. 
LMS decreases cardiac rhythm both in semi-isolated hearts and in vivo. 
LMS RNAi treatment increases heartbeat frequency in females transporting oothecae. 
Results suggest that LMS modulates cardiac rhythm in B. germanica. 
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Abstract 14 
Several lines of evidence point to leucomyosuppressin (LMS) and myosuppressin-15 
related peptides as inhibitory modulators of heartbeat frequency in arthropods. Previous 16 
studies in Blattella germanica demonstrated that heartbeat frequency decreases after 17 
ootheca formation, and remains low during the period of ootheca transport.  Subsequent 18 
work in this cockroach resulted in the characterization of LMS and the cloning and 19 
sequencing of its precursor. The present paper describes the activity of LMS on 20 
modulation of heartbeat in B. germanica. Assays using semi-isolated heart preparations 21 
revealed that LMS reduces heartbeat frequency in a dose dependent manner, at 22 
physiological concentrations. Additional experiments showed that LMS inhibits heart 23 
beat rates in vivo. Finally, injection of dsRNA for LMS elicited a decrease in LMS 24 
mRNA to virtually undetectable levels and heartbeat frequency increased significantly 25 
in females carrying oothecae. These data suggest that LMS contributes to the 26 
modulation of cardiac rhythm in B. germanica during the reproductive cycle. 27 
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1. Introduction 29 
 30 
 Reproduction in cockroaches is characterized by the formation of an egg-case or 31 
ootheca, which protects the oviposited eggs. A number of species drop the ootheca 32 
immediately after its formation, whereas others, which are evolutionarily more 33 
modified, transport it until the emergence of the young (Roth, 1970). The German 34 
cockroach, Blattella germanica, is a good example of this mode of reproduction. It 35 
transports the ootheca attached to the genital atrium for a period of ca. 20 days, during 36 
which the female produces lower rates of juvenile hormone (Gadot et al., 1989; Maestro 37 
et al., 1994), consumes less food (Lee and Wu, 1994; Osorio et al., 1998) and shows a 38 
decreased locomotory activity (Lee and Wu, 1994). Moreover, heartbeat frequency 39 
decreases after ootheca formation, and remains low during the period of ootheca 40 
transport (Vilaplana et al., 1999). Regulatory peptides have been postulated as 41 
modulators of cardiac rhythm, and proposed candidates for such a modulation have 42 
been YXFGLamide allatostatins, with an inhibitory role, and corazonin with a 43 
stimulatory one (Vilaplana et al., 1999). 44 
 However, a number of lines of evidence point to myosuppressin peptides as 45 
repressor modulators of heartbeat frequency in insects. Myosuppressins form a 46 
subfamily of FMRFamide-related peptides (Orchard et al., 2001), and the first member 47 
to be identified was leucomyosuppressin (LMS), with the structure 48 
pQDVDHVFLRFamide, which was isolated from nervous tissues of the cockroach 49 
Leucophaea maderae by monitoring its ability to decrease spontaneous hindgut 50 
contractions (Holman et al., 1986). Subsequent heterologous assays showed that LMS 51 
inhibits the amplitude and frequency of contractions in semi-isolated heart preparations 52 
of the desert locust Schistocerca gregaria (Cuthbert and Evans, 1989), whereas the 53 
endogenous LMS-like peptide of this locust (PDVDHVFLRFamide), also inhibited the 54 
spontaneous contractions of the heart (Robb et al., 1989). In tenebrionid beetles, 55 
cockroach LMS significantly decreased the heartbeat frequency in Tenebrio molitor 56 
(Wasielewski and Skonieczna, 2008), whereas the same peptide, isolated from the 57 
neuroendocrine system of Zophobas atratus, had a similar effect in this species 58 
(Marciniak et al., 2011). In Crustaceans, a neuropeptide with the structure 59 
pQDLDHVFLRFamide, thus belonging to the myosuppressin subfamily, has been 60 
isolated from a number of species (Ma et al., 2008; Stemmler et al., 2007). 61 
Subsequently, the cDNA corresponding to the peptide precursor has been cloned and 62 
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 3 
sequenced in the American lobster Homarus americanus (Stevens et al., 2009), where 63 
the synthetic peptide decreases heartbeat frequency in vivo and in semi-isolated heart 64 
preparations (Stevens et al., 2009). 65 
 In the cockroach B. germanica, we have isolated and chemically characterized 66 
LMS (Aguilar et al., 2004), and we have also cloned and sequenced the cDNA 67 
corresponding to the LMS precursor (Vilaplana et al., 2004). However, we have not 68 
studied the activity of LMS on modulation of heartbeat in this cockroach. The present 69 
contribution aims to establish a possible role of LMS on cardiac rhythm modulation, 70 
using RNAi to silence the expression of the peptide precursor. 71 
 72 
  73 
2. Materials and methods 74 
 75 
2.1. Insects 76 
 77 
 Adult females of B. germanica were obtained from a colony reared with dog 78 
chow and water, in the dark at 30 ± 1C and 60-70% relative humidity. Freshly molted 79 
adult females were isolated and used at the appropriate ages. Virgin females were used 80 
in the experiments, which were carried out during the first 7 days of the gonadotrophic 81 
cycle. To study the period of ootheca transport, mated females were used instead, since 82 
they retain the ootheca throughout the entire period of embryogenesis. 83 
 84 
2.2. Synthetic peptides 85 
 86 
Synthetic version of LMS (pQDVDHVFLRFamide), and the analog of 87 
ManducaFLRFamide with the C-terminus in acid form (pQDVVHSFLRF-OH), were 88 
synthesized in the Proteomics Facility of the Universitat Pompeu Fabra (UPF), using 89 
standard Fmoc chemistry, purified to near-homogeneity (<95%) by HPLC and 90 
characterized by amino acid analysis and MALDI-TOF mass spectrometry. 91 
 92 
2.3. Semi-isolated heart preparations 93 
 94 
 For semi-isolated heart preparations, we used 5-day-old B. germanica females as 95 
previously described (Vilaplana et al., 1999). Briefly, the specimens were pinned 96 
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 4 
ventral side up on a paraffin wax plate and the dorsum with the heart attached was 97 
dissected free. The heart preparation was covered with 500 µL of Ringer saline and 98 
oxygenated with an air flow above the liquid surface. After 20 min, 150 µL of saline 99 
was removed, and the same volume containing the desired concentration of peptide, was 100 
added. Heartbeat frequency was recorded every minute for 5 min and then every 5 min 101 
for 15 min. 102 
 103 
2.4. Recording heart beat rate in vivo  104 
 105 
In the experiments of peptide treatments, 1 µL of a MilliQ water peptide solution 106 
was injected into the abdomen of CO2-anaesthetised 5-day-old adult B. germanica 107 
females. Peptide solution was calculated to obtain the desired peptide concentration (10
-
108 
6
, 10
-7
 or 10
-8
M) in the haemolymph, assuming that a 5-day-old adult B. germanica 109 
female has a haemolymph volume of ca. 25 µL (Romaña et al., 1995) Then, the 110 
specimen was immobilized dorsal side up on a wax plate, the wings were cut off so the 111 
dorsal vessel was visible through the cuticle and the heart beat rate was directly 112 
counted. Heartbeat frequency was recorded every min for 5 min. For recording 113 
heartbeat frequency in the case of dsRNA-treated animals (see 2.6. below), the 114 
procedure was similar, although the specimens were not injected with any peptide 115 
solution. In these cases we recorded heart beat rate for each specimen at least three 116 
times between minutes 5 and 10. 117 
 118 
2.5. Tissue extraction, RNA isolation, cDNA preparation, polymerase chain (PCR) 119 
reaction, and Southern-blot analysis 120 
 121 
 Brains and midguts from 5- and 12-day-old females (the later ones carrying the 122 
oothecae) were dissected and immediately frozen in liquid nitrogen. RT-PCR followed 123 
by Southern blotting was used to estimate mRNA levels. cDNA was synthesized from 124 
total RNA as previously described (Maestro and Belles, 2006). One µg of total RNA 125 
was used for reverse transcription in the case of midguts, whereas in the case of brains, 126 
the whole RNA from one brain was used. To estimate mRNA levels semi-127 
quantitatively, a non-saturating number of cycles in the PCR system were used. Primers 128 
used for amplifying LMS were: forward, 5’-CAGCATCAGAATGAAGTACGTCAG-129 
3’, reverse, 5’-AACATTTGTTTACTGTACTGGCCAA-3’. As a reference, the same 130 
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 5 
cDNAs were amplified with a primer pair specific for Actin-5C (Maestro et al., 2005). 131 
cDNA probes for Southern blot analyses were generated by PCR with the same primer 132 
pairs and labeled with fluorescein, using the Gene Images random prime-labeling 133 
module (Amersham Biosciences). 134 
 135 
2.6. RNA interference 136 
 137 
 Systemic RNAi in vivo in females of B. germanica was performed as previously 138 
described (Maestro and Belles, 2006; Maestro et al., 2009). A 635-bp fragment 139 
spanning positions 95 to 729 of the BgLMS cDNA (Vilaplana et al., 2004) was used to 140 
generate a dsRNA (dsLMS). As a control, a heterologous sequence of 307 bp from the 141 
polyhedrin of Autographa californica nucleopolyhedrovirus (dsMock) was used. A dose 142 
of 2 µg was injected into the abdomen of freshly molted adult females. Recording of 143 
heart beat rate in vivo and tissue dissections were performed at the indicated ages. 144 
 145 
 146 
3. Results 147 
 148 
3.1. LMS inhibits heartbeat frequency on semi-isolated heart preparations 149 
  150 
 To gain an initial insight into the possible role of LMS on B. germanica heart 151 
beating, we studied the effect of various concentrations of the synthetic peptide (10
-6
, 152 
10
-7
 and 10
-8
M) on semi-isolated heart preparations. As a negative control, we tested 153 
pQDVVHSFLRF-OH at 10
-6
M. Results (Fig. 1) show that heartbeat frequency 154 
remained more or less constant (around 30 beats/15 s), although tending to increase 155 
slightly, during the first 20 min, whereas the administration of LMS produced a fast, 156 
dose-dependent and reversible inhibition. The doses of 10
-6
 and 10
-7
M elicited 49% and 157 
25% inhibition, respectively. Heartbeat frequency at a dose of 10
-8
M tended to be 158 
reduced (by 14%) but did not significantly differ from that measured in the pre-159 
treatment. Treatments with pQDVVHSFLRF-OH did not elicit any apparent response 160 
(Fig. 1). 161 
 162 
3.2. LMS reduces heartbeat frequency in vivo  163 
 164 
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 The effect of LMS on heartbeat frequency was studied in vivo on 5-day-old adult 165 
virgin females. Assuming that the average volume of haemolymph in a female of this 166 
age is of ca. 25 µL (Romaña et al., 1995), we injected the appropriate dose in 1 µL 167 
solution to reach final haemolymph peptide concentrations of 10
-6
, 10
-7
 and 10
-8
M, just 168 
as in the experiments carried out on semi-isolated heart preparations. Also in this case, 169 
we used pQDVVHSFLRF-OH at 10
-6
M, as a negative control, and additional control 170 
specimens that received only 1 µL water were used. Results (Fig. 2) indicated that the 171 
treatment in vivo with LMS also produced a fast, dose-dependent and reversible 172 
decrease in heartbeat frequency. Differences were most striking 1 min after the 173 
treatment, when the dose of 10
-6
M elicited an 86% decrease, whereas that of 10
-7
M gave 174 
55%. Neither the dose of 10
-8
M of LMS, nor that of 10
-6
M of pQDVVHSFLRF-OH 175 
elicited significant differences with respect to water controls (Fig. 2). 176 
 177 
3.3. RNAi treatment decreases LMS mRNA levels 178 
 179 
 Freshly molted adult females were treated with dsLMS, maintained without 180 
males and killed on day 5 of adult life, to dissect out the brain and the midgut for RT-181 
PCR analysis. A second group was similarly treated, but maintained with males and 182 
killed on day 12, during the period of ootheca transport. All the later females formed 183 
oothecae correctly around day 7, as is usual in our colony (Aguilar et al., 2003). 184 
Equivalent experiments were carried out with dsMock. Tissues were processed, and 185 
results (Fig. 3) showed that LMS mRNA was virtually undetectable in both brain and in 186 
midgut tissues in dsLMS-treated specimens on day 5. Expression in dsLMS-treated 187 
specimens was still undetectable on day 12. Expression of LMS mRNA was well 188 
apparent in dsMock-treated specimens (Fig. 3). 189 
 190 
3.4. LMS knockdown increases heartbeat frequency 191 
 192 
 Using the same experimental design, on day 5 and day 12 of adult life we 193 
measured heart beating in adult females that had been treated with dsLMS or dsMock 194 
when freshly emerged. Results (Fig. 4) showed that on day 5, heartbeat frequency in 195 
dsLMS-treated specimens (37.6 + 0.4 beats/15 s, n = 23) tended to be higher than in the 196 
dsMock-treated group (36.8 + 0.4 beats/15 s, n = 22), but differences were not 197 
statistically significant (t test, p = 0.0653) (Fig. 4). On day 12, in animals carrying 198 
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 7 
oothecae, heartbeat frequency in dsLMS-treated specimens (35.2 + 0.4 beats/15 s, n = 199 
25) was significantly higher (t test, p = 0.0153) than in the dsMock-treated specimens 200 
(33.5 + 0.5 beats/15 s, n = 24) (Fig. 4). 201 
 202 
 203 
4. Discussion 204 
 205 
 Experiments on semi-isolated heart preparations showed that LMS reduces 206 
heartbeat frequency in a dose dependent manner, with threshold concentrations between 207 
10
-8
M and 10
-7
M. These concentrations can be considered physiological for a peptide 208 
serving as a circulating hormone. Heterologous assays following this system in vitro 209 
with the desert locust, S. gregaria, used concentrations of LMS of 10
-6
M to effectively 210 
decrease heartbeat frequency (Cuthbert and Evans, 1989). Later, it was shown that the 211 
endogenous LMS-like peptide of S. gregaria (PDVDHVFLRFamide) also decreased the 212 
spontaneous contractions of the heart at a concentration of 10
-6
M (Robb et al., 1989). 213 
Effective concentrations of LMS used in semi-isolated heart preparations of the 214 
tenebrionid beetle T. molitor were between 10
-7
M and 10
-6
M (Wasielewski and 215 
Skonieczna, 2008), whereas LMS, identified from brain and retrocerebral complex of Z. 216 
atratus, another tenebrionid, inhibited heart contractions of this insect with threshold 217 
concentrations of 10
-8
-10
-7
M (Marciniak et al., 2011). Therefore, the active 218 
concentrations found in our experiments using semi-isolated heart preparations with B. 219 
germanica are consistent with the results obtained in other insects using similar 220 
methods. These concentrations are also similar to those used in heart preparations of the 221 
American lobster, H. americanus, and its native LMS-like peptide, 222 
pQDLDHVFLRFamide (Stevens et al., 2009). In this crustacean, concentrations tested 223 
to inhibit heart beating were between 10
-9
M and 10
-6
M, the effects were dose-224 
dependent, and the threshold concentrations were 10
-8
-10
-7
M (Stevens et al., 2009). 225 
 Our experiments also showed that LMS inhibits heart beat rates in vivo in B. 226 
germanica. This approach in vivo has been used in H. americanus, in which an initial 227 
concentration of ca. 10
-7
M in the pericardial cavity significantly decreased the heartbeat 228 
frequency (Stevens et al., 2009), a concentration that is within the range of effective 229 
concentrations used in our experiments in vivo. In the case of H. americanus, however, 230 
the effects of myosuppressin injections into intact specimens were relatively long-231 
lasting, with a recovery of basal heartbeat frequency taking between 25 min to 1 h. In B. 232 
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 8 
germanica, return to normal frequency took only between 1 and 2 min. This fast 233 
recovery suggests that LMS is rapidly degraded by enzymes in the internal milieu of the 234 
intact cockroach. Indeed, LMS was shown to be degraded in diluted haemolymph of the 235 
moths Spodoptera littoralis and Lacanobia oleracea, with a half-life of 13.1 and 65.4 236 
min, respectively, and degradation was faster in diluted contents of the midgut lumen of 237 
the two species (half-life of 0.5 min in L. oleracea, and 2.2 min in S. littoralis) 238 
(Matthews et al., 2009). Degradation of LMS in B. germanica has not been studied, but 239 
a study in vivo combining the use of a radioiodinated derivative of the allatostatin 240 
DRLYSFGLamide, microdialysis techniques and HPLC analysis with a radioisotope 241 
detector, determined that the half-life of this peptide in the internal milieu of the adult 242 
female of B. germanica is ca. 4 min (Peralta et al., 2000). 243 
 The RNAi experiments described herein showed that treatment with dsLMS 244 
decreases LMS mRNA to virtually undetectable levels, whereas heartbeat frequency 245 
increases significantly in females transporting oothecae. Effectiveness of dsRNA 246 
treatment for target transcript reduction is not surprising, given that B. germanica has 247 
proven to be very sensitive to RNAi in vivo (Belles, 2010). The derived increase in 248 
heartbeat frequency is modest: only a tendency when measured on day 5, during full 249 
vitellogenesis, and a modest although statistically significant increase from 33 beats/15 250 
sec to 35 beats/15 sec, when measured on day 12, during the period of ootheca 251 
transport. However, this should be expected in a physiological context if we consider 252 
that the cardiac rhythm when the insect forms the ootheca is only reduced about 7-8 253 
beats/15 sec (Figure 4A) (Vilaplana et al., 1999). If we hypothesize that such a 254 
reduction is regulated by myoinhibitory peptides, then the increase that we can expect 255 
when we reduce the expression of such peptides may be within this order of magnitude. 256 
The fact that differences between dsLMS-treated and controls on day 5 (during 257 
vitellogenesis, previous to ootheca formation) were non significant, in contrast with the 258 
significant differences observed on day 12 (during ootheca carrying), may be due to the 259 
different physiological status of these two ages. For example, the lower heartbeat rate 260 
measured in ootheca carrying females might be more affected by inhibitory signals (like 261 
LMS), thus more prone to show RNAi effects. An additional possibility may be related 262 
to differences in peptide decay rates due to differences in the duration of the treatment. 263 
In a similar work studying B. germanica preproallatostatin (Maestro and Belles, 2006), 264 
mRNA and peptide levels were analyzed after RNAi, and brain mRNA was reduced 265 
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 9 
close to undetectable levels, whereas brain allatostatin peptide showed 48% and 79% 266 
reduction at day 6 and day 14, respectively. 267 
 If LMS inhibits heartbeat frequency when the ootheca is formed, then we should 268 
expect that LMS expression should be up-regulated at this time. However, LMS mRNA 269 
levels in brain tissues of B. germanica are quite constant during the first gonadotrophic 270 
cycle and first days of ootheca transport (Vilaplana et al., 2004). This suggests that the 271 
regulation must be produced at other points, as, for example, in peptide levels, by 272 
modulation of the translation of the precursor mRNA, the peptide release or the peptide 273 
degradation or at the level of LMS receptor at the heart, among other possibilities. 274 
Moreover, the possibility that other peptides contribute to regulation of cardiac rhythm 275 
cannot be ruled out. Allatostatins and corazonin are additional obvious candidates to 276 
modulate heartbeat frequency in an inhibitory or stimulatory way, respectively 277 
(Vilaplana et al., 1999). However, LMS appears to be a good candidate as a 278 
physiological regulator of cardiac rhythm from an evolutionary perspective. Indeed, the 279 
fact that myosuppressins have cardioinhibitory properties in insects and crustaceans 280 
suggests that modulation of heartbeat frequency might have been an ancestral function 281 
of this family of peptides in arthropods. 282 
  283 
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Figure legends 376 
 377 
Fig. 1. Effect of LMS (10
-6
, 10
-7
, 10
-8
 M) and pQDVVHSFLRL-OH (10
-6
 M) on 378 
heartbeat rate in 5-day-old Blattella germanica semi-isolated heart preparations. The 379 
peptides were applied (arrow) after a 20 min stabilization period. Results are expressed 380 
as the mean ± SEM (n = 5-7). Asterisks indicate significant differences between values 381 
before and after the treatment (Student’s t-test: *P<0.05; **P <0.005). 382 
 383 
 384 
Fig. 2. Heartbeat rate in 5-day-old Blattella germanica females after treatment in vivo 385 
with LMS (10
-6
, 10
-7
, 10
-8
 M), pQVVHSFLRL-OH (10
-6
 M) or water. Heartbeat rate 386 
was counted every minute for 5 minutes immediately after peptide injection. Results are 387 
expressed as the mean ± SEM (n = 8-13). Asterisks indicate significant differences 388 
between peptide and control treatments (Student’s t-test: *P<0.05; **P <0.0005; *** P 389 
<0.0001). 390 
 391 
 392 
Fig. 3. Silencing LMS expression in Blattella germanica females. Specimens were 393 
treated immediately after the imaginal molt. LMS mRNA in brain and midgut from 394 
dsMock- and dsLMS-treated specimens were analyzed using RT-PCR, followed by 395 
Southern-blot. Actin-5C mRNA levels were used as a reference. –RT: Negative controls 396 
without the reverse transcriptase step. 397 
 398 
 399 
Fig. 4. Effect of dsLMS treatment on heartbeat rate in Blattella germanica females. A. 400 
Cardiac rhythm during the first reproductive cycle (data from (Vilaplana et al., 1999)). 401 
B. Heartbeat rate in dsMock- and dsLMS-treated adult females. Specimens were treated 402 
immediately after the imaginal molt and heartbeat rate was measured in vivo at days 5 403 
and 12. Results are expressed as the mean ± SEM (n = 22-25). Asterisk indicates 404 
significant differences (Student’s t-test: *P<0.05). 405 
pQDVVHSFLRF-OH 10  M
-6
0
5
10
15
20
25
30
35
40
45
0 5 10 15 20 25 30 35 40
b
e
a
ts
/1
5
 s
e
c
Time (min)
*
LMS 10  M
-7
0
5
10
15
20
25
30
35
40
45
0 5 10 15 20 25 30 35 40
b
e
a
ts
/1
5
 s
e
c
Time (min)
LMS 10  M
-8
0
5
10
15
20
25
30
35
40
45
0 5 10 15 20 25 30 35 40
b
e
a
ts
/1
5
 s
e
c
Time (min)
LMS 10  M
0
5
10
15
20
25
30
35
40
45
-6
0 5 10 15 20 25 30 35 40
b
e
a
ts
/1
5
 s
e
c
Time (min)
**
Figure(s)
05
10
15
20
25
30
35
40
0 1 2 3 4 5
***
*
**
Time (min)
b
e
a
ts
/1
5
 s
e
c
10  M LMS
-6
10  M LMS
-7
10  M LMS
-8
10  M pQDVVHSFLRF-OH
-6
Water
Figure(s)
Actin-5C
LMS
dsMock dsLMS -RT dsMock dsLMS -RT
day 5 day 12Midgut
Brain
Actin-5C
LMS
dsMock dsLMS -RT dsMock dsLMS -RT
day 5 day 12
Figure(s)
25
30
35
40
b
e
a
ts
/1
5
 s
e
c
10 2 3 4 5 6 7 8 10 12
Age (days)
A
b
e
a
ts
/1
5
 s
e
c
b
e
a
ts
/1
5
 s
e
c
30
32
34
36
38
40
30
32
34
36
38
40
*
dsMock dsLMS dsMock dsLMS
day 5 day 12
B
Figure(s)
